Avila Partnership, PTV News: May 26, 2010




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Avila Partnership, PTV News: May 26, 2010
Released on: May 26, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
Clovis signs second oncology deal in first year
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Kate Moore
Director
PharmaVentures

Kate has 15 years of experience in the biotechnology industry, most recently as Director of Business Development at TopoTarget. Kate has a successful track record in negotiating in- and out- licensing deals, conducting market evaluations and technical and commercial due diligence. Kate has also held positions in marketing and research at BD Biosciences, BioCarta and Prolifix. Kate has an undergraduate degree from Oxford University and a PhD in Molecular Biology from University College London.
Avila Therapeutics
Avila Therapeutics is a life sciences company aiming to discover and develop novel small molecule drugs. The firm's focuses on the areas of cancer and autoimmune.
Clovis Oncology
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercialising innovative anti-cancer agents in the U.S., Europe and additional international markets.